| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Jun 22, 2023 |
|||||||||
|
Darden Restaurants
DRI
|
Q4 FY23 | $2.58 | $2.54 | $2.77B | $2.77B |
NYSE |
|||
|
Commercial Metals
CMC
|
Q3 FY23 | $2.02 | $1.76 | $2.34B | $2.23B |
NYSE |
|||
|
GMS
GMS
|
Q4 FY23 | $2.11 | $1.89 | $1.30B | $1.27B |
NYSE |
|||
|
FactSet Research Systems
FDS
|
Q3 FY23 | $3.79 | $3.61 | $529.81M | $527.33M |
NYSE |
|||
|
Methode Electronics
MEI
|
Q4 FY23 | $0.22 | $0.46 | $301.20M | $297.45M |
NYSE |
|||
|
Smith & Wesson Brands
SWBI
|
Q4 FY23 | $0.28 | $0.27 | $144.78M | $138.38M |
NASDAQ |
|||
|
CaliberCos
CWD
|
- | -$0.07 | - | $29.52M | - |
NASDAQ |
|||
|
Crown Crafts
CRWS
|
Q4 FY23 | $0.08 | $0.23 | $21.61M | $22.30M |
NASDAQ |
|||
|
Beyond Air
XAIR
|
Q4 FY23 | -$13.40 | -$8.80 | - | $720K |
NASDAQ |
|||
|
VistaGen Therapeutics
VTGN
|
- | -$1.75 | -$1.50 | $175.60K | $179.60K |
NASDAQ |
|||
